First elected: 5th May 2005
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
These initiatives were driven by Sharon Hodgson, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Sharon Hodgson has not been granted any Urgent Questions
Sharon Hodgson has not been granted any Adjournment Debates
The Bill failed to complete its passage through Parliament before the end of the session. This means the Bill will make no further progress. A Bill to regulate the selling of tickets for certain sporting and cultural events; and for connected purposes.
Nurse (Use of Title) Bill 2024-26
Sponsor - Dawn Butler (Lab)
Theft of Tools of Trade (Sentencing) Bill 2024-26
Sponsor - Amanda Martin (Lab)
Public Sector Websites (Data Charges) Bill 2023-24
Sponsor - Simon Lightwood (LAB)
Brain Tumours Bill 2022-23
Sponsor - Siobhain McDonagh (Lab)
Quad Bikes Bill 2021-22
Sponsor - Judith Cummins (Lab)
Breast Screening Bill 2021-22
Sponsor - Steve Brine (Con)
Education (Guidance about Costs of School Uniforms) Act 2021
Sponsor - Mike Amesbury (Ind)
Goods and Services of UK Origin Bill 2019-21
Sponsor - Gareth Thomas (LAB)
Smoking Prohibition (National Health Service Premises) Bill 2017-19
Sponsor - Tracy Brabin (LAB)
Reproductive Health (Access to Terminations) Bill 2016-17
Sponsor - Diana Johnson (Lab)
The Period Poverty Taskforce was an initiative under a previous government, and last met in 2020. I thank them for their hard work.
Rather than re-launch a standalone initiative, this Government's approach is to resolve the issue at the source by tackling the reasons women and girls are pushed into period poverty to start with. We are protecting women’s living standards, alongside the public services they rely on, so that no one has to go without life's essentials.
The UK Government works closely and discusses a range of matters with colleagues in the Welsh Government. Consideration of the effectiveness of devolved legislation is a matter for the relevant devolved legislature and government. The Cabinet Office therefore has not carried out a specific assessment of the effectiveness of the Well-being of Future Generations Act 2015.
The transfer of the Mineworkers’ Pension Scheme investment reserve was a manifesto commitment which the Government has fulfilled. The BCSSS scheme has some differences to the MPS, but we are working with the BCSSS Trustees to consider their proposals.
Under the Online Safety Act, platforms must proactively tackle the most harmful illegal content including extreme pornography, much of which disproportionately affects women and girls. The Act requires services in scope to understand risks from illegal content online and take mitigating action.
Separate to provisions in the Online Safety Act, the Independent Pornography Review, led by Independent Lead Reviewer Baroness Gabby Bertin will explore the effectiveness of regulation, legislation and the law enforcement response to pornography. The government expects the Review to present its final report by the end of the year.
The Government is committed to keeping children safe online. Our priority is the effective implementation of the Online Safety Act so that children benefit from its wide-reaching protections.
The Act requires that all in scope services that allow pornography use highly effective age assurance to prevent children from accessing it, including services that host user-generated content, and services which publish pornography. Ofcom has robust enforcement powers available against companies who fail to fulfil their duties.
On the 22nd of January, I was pleased to announce that the Listed Places of Worship Grant Scheme would continue from March 2025 to March 2026 with a budget of £23m. Further details can be found in this Written Statement.
Both myself and my officials have met with a range of stakeholders since July 2024 and discussed as part of those meetings the future and impact of the Listed Places of Worship Grant Scheme. The Department also received and responded to a large number of correspondence on the scheme including from representatives from faith communities sharing their views.
The early adopter scheme will test and learn how schools are able to use programme funding, support and guidance to ensure inclusive and accessible provision for children with special educational needs and disabilities, in a range of schools, including special schools and alternative provision (AP).
In recognition of the need for higher staff to pupil ratios in these settings, special schools and AP will receive a higher funding rate per pupil in addition to the fixed termly payments and set up cost funding.
The Music and Dance Scheme grant funding of both private schools and Centres for Advanced Training relates to financing places via means-tested bursaries only and is not intended as direct funding to meet wider employment costs.
.
The government is committed to delivering the Lifelong Learning Entitlement (LLE) as set out in the Autumn Budget statement in October 2024. From the LLE’s launch in January 2027, the Office for Students (OfS) will regulate all providers offering LLE-funded provision.
The OfS has made clear that it expects to restart work on registrations, degree awarding powers and university titles in August 2025, although the changes will remain under review until then. The department understands the OfS will keep providers updated throughout this period about its plans, including confirming application arrangements from August onwards. The government supports the reasons for the temporary pause so that the OfS can refocus its efforts on provider financial sustainability. As the independent regulator, it is for the OfS to process registrations in the manner it deems most appropriate.
The government will continue to engage closely with the OfS and providers to support timely transition arrangements for the launch of the LLE. The government, together with the OfS, will provide further information on the regulation of providers under the LLE in spring 2025.
The government is committed to delivering the Lifelong Learning Entitlement (LLE) as set out in the Autumn Budget statement in October 2024. From the LLE’s launch in January 2027, the Office for Students (OfS) will regulate all providers offering LLE-funded provision.
The OfS has made clear that it expects to restart work on registrations, degree awarding powers and university titles in August 2025, although the changes will remain under review until then. The department understands the OfS will keep providers updated throughout this period about its plans, including confirming application arrangements from August onwards. The government supports the reasons for the temporary pause so that the OfS can refocus its efforts on provider financial sustainability. As the independent regulator, it is for the OfS to process registrations in the manner it deems most appropriate.
The government will continue to engage closely with the OfS and providers to support timely transition arrangements for the launch of the LLE. The government, together with the OfS, will provide further information on the regulation of providers under the LLE in spring 2025.
Section 100 of the Children and Families Act 2014 places a duty on maintained schools, academies and pupil referral units to make arrangements for supporting pupils with medical conditions. Some children with medical conditions may be considered to be disabled under the definition set out in the Equality Act 2010. Where this is the case, governing bodies must comply with their duties under that Act.
Governing bodies should ensure that all schools develop a policy for supporting pupils with medical conditions that is reviewed regularly and is readily accessible to parents and school staff. They must ensure that the arrangements they put in place are sufficient to meet their statutory responsibilities and should ensure that policies, plans, procedures and systems are properly and effectively implemented.
The statutory guidance ‘Supporting pupils at school with medical conditions’ recommends the use of individual healthcare plans as good practice. They can help schools support pupils with medical conditions, providing clarity about what needs to be done, when and by whom. The school, healthcare professionals and parents should agree, based on evidence, when a healthcare plan would be appropriate. The guidance can be found here: https://assets.publishing.service.gov.uk/media/5ce6a72e40f0b620a103bd53/supporting-pupils-at-school-with-medical-conditions.pdf.
We do not hold data on the impact of period poverty on educational attainment in England.
The Period Products Scheme removes periods as a barrier to accessing education and addresses pupils being unable to afford period products. Since its launch in January 2020, 99% of secondary schools and 87% of post-16 organisations in England have placed orders through the scheme.
The holiday activities and food programme (HAF) supports disadvantaged children and their families during the Easter, summer and Christmas holidays with enriching activities, providing them with healthy food, helping them to learn new things, improving socialisation and benefiting their health and wellbeing during school holidays.
The HAF programme guidance sets out that: “While the majority of funding that local authorities receive should be used for holiday club places for children in receipt of free school meals (FSM), local authorities have discretion to use up to 15% of their funding to provide free or subsidised holiday club places for children who are not in receipt of benefits-related FSM, but who the local authority believe could benefit from HAF provision”.
The government is committed to delivering an ambitious strategy to reduce child poverty by tackling the root causes and giving every child the best start in life. To support this, a new Ministerial taskforce has been set up to develop a Child Poverty Strategy. The taskforce will consider a range of policies, assessing what will have the greatest impact in driving down rates of child poverty. As with all policies, the government keeps the approach to free school meals under review.
The Secretary of State has regular discussions with Cabinet colleagues on a range of issues. No recent discussions have taken place between the Secretary of State and the Chancellor of the Exchequer on the subject of mandatory food waste reporting.
This Government is committed to setting a clear roadmap to a circular economy – a future where our resources are used as efficiently and productively as possible for as long as possible, and waste is reduced. We are reviewing policies to address the challenges associated with tackling food waste in the supply chain and we are working with businesses to drive down food waste and make sure food is put on the plates of those in greatest need. This includes supporting surplus food redistribution to charities and programmes to help citizens reduce their food waste.
In our manifesto, the Government committed to reducing waste by moving to a circular economy.
The Secretary of State has convened a Small Ministerial Group on Circular Economy and a Circular Economy Taskforce of experts across government, industry, academia, and civil society has been established to help develop a Circular Economy Strategy for England and a series of roadmaps detailing the interventions that the Government will make on a sector-by-sector basis. Preventing food waste will be a key part of this work and we will consider the evidence for action right across the economy to evaluate what interventions may be needed as we develop the strategy.
The Government is committed to setting a clear roadmap to a circular economy – a future where our resources are used as efficiently and productively as possible for as long as possible, and waste is reduced. Preventing food waste will be a key part of this work, and the Department is reviewing a range of issues associated with food waste in the supply chain, including mandatory food waste reporting requirements. These will be announced in due course.
Food Security is national security which is relevant to all five Government Missions and central to our primary Mission to grow the economy. Boosting Britain’s food security is one of the core priorities of this Government.
We need a resilient and healthy food system, that works with nature and supports British Farmers. The only way to do this effectively is to listen to farmers and others with a stake in our food system, countryside, and nature. We will consider relevant evidence and analysis, including that contained in Henry Dimbleby’s National Food Strategy, as we develop our plans to support our farmers and food and drink businesses, boost food security, invest in rural communities, deliver growth, manage waste more effectively across the supply chain, improve resilience to climate change and tackle biodiversity loss.
The Government is committed to setting a clear roadmap to a circular economy – a future where our resources are used as efficiently and productively as possible for as long as possible, and waste is reduced. Preventing food waste will be a key part of this work, and the Department is reviewing a range of issues associated with food waste in the supply chain, including mandatory food waste reporting requirements. These will be announced in due course.
Ensuring the safety of passengers on the rail network is a priority for the department. We work closely with BTP, the rail industry, and Home Office police forces for cross government strategies to tackle violence against women and girls, and we have ambitions in this space to reduce offences on the transport network.
There are currently no plans to change existing roles and responsibilities regarding safety and tackling crime and anti-social behavior. The British Transport Police will continue to police the rail network in England, Scotland and Wales.
Tackling Violence Against Women and Girls (VAWG) is a priority for the Government. We have set ourselves the ambitious target to halve VAWG offences in the next decade using every lever available to us.
My Department and the rail industry, including the British Transport Police are committed to ensuring the safety of women and girls on trains. As we deliver rail reform, we will ensure that plans are in place to build on the good work being done by the rail industry to improve the safety of the rail network for all who use it.
The department and ministers are in regular contact with the British Transport Police (BTP), who are a member of the National Police Chiefs Council, regarding their commitment to tackling VAWG offences on the rail network. The Force are a key partner in supporting the Government’s mission to take back our streets which includes a commitment to halve VAWG offences in the next decade.
The British Transport Police (BTP) are responsible for policing the rail network in England, Scotland and Wales. The force has provided the following information on arrests and prosecutions against female victims for Violence, Sex and Public Order (Serious) offences in the previous 5 calendar years.
Arrests
Year* | 2020 | 2021 | 2022 | 2023 | 2024 |
Number of victims | 819 | 930 | 1156 | 1132 | 1222 |
Prosecutions
Year* | 2020 | 2021 | 2022 | 2023 | 2024 |
Number of victims | 956 | 1031 | 1207 | 1197 | 856 |
*To note 1) passenger numbers were reduced in 2020 and 2021 due to the Covid-19 pandemic, which resulted in reduced numbers of crimes and arrests; 2) Arrest and any subsequent prosecution may not occur in the same calendar year.
Personal Independence Payment (PIP) is a benefit for people with a long-term health condition or impairment, whether physical, sensory, mental, cognitive, intellectual, or any combination of these. It is paid to contribute to the extra costs that disabled people may face, to help them lead full, active and independent lives. PIP can be paid to those who are in full or part-time work as well as those out of work.
From 09 September 2024 Department for Work and Pensions (DWP) took ownership of the core training and guidance material (CTGM) for the Health Assessment Advisory Service (HAAS); this is provided by DWP to the HAAS assessment suppliers (AS). AS must use the material to inform the development of their final training product(s) and use all content from CTGM that relates to specific condition(s) and assessment policy.
DWP has provided AS with CTGM on mesh injury/implants. This contains clinical and functional information relevant to the condition and is quality assured to ensure its accuracy from both a clinical and policy perspective.
Under the Enhanced health in care homes framework, every care home must be aligned to a primary care network (PCN) and must have established protocols between the PCN, the care home, and system partners, such as local general practices and pharmacies, for information sharing, shared care planning, use of shared care records, and clear clinical governance.
Pharmacies are expected to maintain a reasonable stock holding to meet their legal obligations to dispense all prescriptions, including to patients in care homes, with reasonable promptness, recognising that it is not feasible for a pharmacy to maintain stock of every medicine. The Pharmacy Quality Scheme rewards community pharmacy contractors that deliver quality criteria, one of which is the Palliative and End of Life Care scheme. Participating pharmacy contractors must declare if they intend to routinely stock 16 critical end of life medicines, including controlled drugs such as morphine and midazolam and/or parenteral haloperidol, and must have an action plan in place to support local access. This enables palliative medicines to be quickly sourced when prescribed.
Most care homes with nursing can hold stocks of controlled drugs and will not require a licence to access medicines containing controlled drugs for patients who need them. This is because care homes run by public authorities or charities are exempt from the need for a Home Office controlled drug licence. Care homes without nursing cannot store controlled drugs unless they are prescribed for individual residents.
The Government seeks to have a coordinated approach to prevent wastage as much as possible, to improve inefficiencies and reduce costs for the taxpayer. PCNs are required to ensure that Structured Medication Reviews (SMRs) for high-risk cohorts, such as care home patients, are implemented. SMRs are an evidence based comprehensive review of a person’s medication, their views, concerns, and safety. The use of SMRs can reduce harmful polypharmacy and medicine wastage.
Under the Enhanced health in care homes framework, every care home must be aligned to a primary care network (PCN) and must have established protocols between the PCN, the care home, and system partners, such as local general practices and pharmacies, for information sharing, shared care planning, use of shared care records, and clear clinical governance.
Pharmacies are expected to maintain a reasonable stock holding to meet their legal obligations to dispense all prescriptions, including to patients in care homes, with reasonable promptness, recognising that it is not feasible for a pharmacy to maintain stock of every medicine. The Pharmacy Quality Scheme rewards community pharmacy contractors that deliver quality criteria, one of which is the Palliative and End of Life Care scheme. Participating pharmacy contractors must declare if they intend to routinely stock 16 critical end of life medicines, including controlled drugs such as morphine and midazolam and/or parenteral haloperidol, and must have an action plan in place to support local access. This enables palliative medicines to be quickly sourced when prescribed.
Most care homes with nursing can hold stocks of controlled drugs and will not require a licence to access medicines containing controlled drugs for patients who need them. This is because care homes run by public authorities or charities are exempt from the need for a Home Office controlled drug licence. Care homes without nursing cannot store controlled drugs unless they are prescribed for individual residents.
The Government seeks to have a coordinated approach to prevent wastage as much as possible, to improve inefficiencies and reduce costs for the taxpayer. PCNs are required to ensure that Structured Medication Reviews (SMRs) for high-risk cohorts, such as care home patients, are implemented. SMRs are an evidence based comprehensive review of a person’s medication, their views, concerns, and safety. The use of SMRs can reduce harmful polypharmacy and medicine wastage.
The Government is committed to improving the diagnosis, treatment, and ongoing care of gynaecological conditions, including ovarian cancer. NHS England has taken urgent action to address gynaecology waiting lists through the Elective Recovery Plan, including support for innovative care models that bring services closer to patients, and the piloting of gynaecology pathways within community diagnostic centres.
As a first step towards improving the diagnosis of ovarian cancer and reducing misdiagnosis, the National Health Service is now delivering an extra 40,000 operations, scans, and appointments each week. The NHS is also improving pathways to get people diagnosed once they are referred, including non-specific symptom pathways for patients who do not fit clearly into a single urgent cancer referral pathway. Combined, these interventions will help ensure early diagnosis and faster treatment, including for women with ovarian cancer, with further actions to be outlined in the forthcoming National Cancer Plan.
The most recent data available from the National Disease Registration Service shows that in England in 2022, 3,151 people were diagnosed with ovarian cancer at stages 3 & 4, which is classed as advanced.
The Government is committed to improving the diagnosis, treatment, and ongoing care of gynaecological conditions, including ovarian cancer. NHS England has taken urgent action to address gynaecology waiting lists through the Elective Recovery Plan, including support for innovative care models that bring services closer to patients, and the piloting of gynaecology pathways within community diagnostic centres.
As a first step towards improving the diagnosis of ovarian cancer and reducing misdiagnosis, the National Health Service is now delivering an extra 40,000 operations, scans, and appointments each week. The NHS is also improving pathways to get people diagnosed once they are referred, including non-specific symptom pathways for patients who do not fit clearly into a single urgent cancer referral pathway. Combined, these interventions will help ensure early diagnosis and faster treatment, including for women with ovarian cancer, with further actions to be outlined in the forthcoming National Cancer Plan.
The most recent data available from the National Disease Registration Service shows that in England in 2022, 3,151 people were diagnosed with ovarian cancer at stages 3 & 4, which is classed as advanced.
The Government is committed to improving the diagnosis, treatment, and ongoing care of gynaecological conditions, including ovarian cancer. NHS England has taken urgent action to address gynaecology waiting lists through the Elective Recovery Plan, including support for innovative care models that bring services closer to patients, and the piloting of gynaecology pathways within community diagnostic centres.
As a first step towards improving the diagnosis of ovarian cancer and reducing misdiagnosis, the National Health Service is now delivering an extra 40,000 operations, scans, and appointments each week. The NHS is also improving pathways to get people diagnosed once they are referred, including non-specific symptom pathways for patients who do not fit clearly into a single urgent cancer referral pathway. Combined, these interventions will help ensure early diagnosis and faster treatment, including for women with ovarian cancer, with further actions to be outlined in the forthcoming National Cancer Plan.
The most recent data available from the National Disease Registration Service shows that in England in 2022, 3,151 people were diagnosed with ovarian cancer at stages 3 & 4, which is classed as advanced.
The following table shows the count of Finished Consultant Episodes (FCEs) where there was any procedure for 'hernia mesh surgeries', recorded for the years 2004/05 to 2023/24, in English National Health Service hospitals and English NHS commissioned activity in the independent sector:
Year | FCEs |
2004/05 | 77,849 |
2005/06 | 79,748 |
2006/07 | 83,789 |
2007/08 | 89,063 |
2008/09 | 87,401 |
2009/10 | 85,519 |
2010/11 | 85,697 |
2011/12 | 90,593 |
2012/13 | 89,676 |
2013/14 | 95,608 |
2014/15 | 95,854 |
2015/16 | 92,147 |
2016/17 | 93,887 |
2017/18 | 89,016 |
2018/19 | 89,951 |
2019/20 | 81,780 |
2020/21 | 39,034 |
2021/22 | 70,884 |
2022/23 | 78,917 |
2023/24 | 83,045 |
Source: Hospital Episode Statistics, NHS England.
Clinicians are expected to inform patients about risks associated with recommended treatments, including reasonable alternatives, to enable informed consent and a balanced patient decision.
The 10-Year Health Plan will deliver the three big shifts our National Health Service needs to be fit for the future: from hospital to community; from analogue to digital; and from sickness to prevention. All of these are relevant to improving arthritis care for children and young people in all parts of the country.
More tests and scans delivered in the community, better joint working between services, and greater use of apps and wearable technology will all support children, young people, and their families to manage their long-term conditions, including arthritis, closer to home.
The Department has not yet considered the recommendations of the report published by the National Confidential Enquiry into Patient Outcome and Death on 13 February 2025, Joint Care? A review of the quality of care provided to children and young adults with juvenile idiopathic arthritis.
NHS England Specialised Commissioning has a Clinical Reference Group for specialised paediatric rheumatology, which has produced a service specification for these services. This service specification names juvenile idiopathic arthritis as one of the conditions that should be managed by a specialist paediatric rheumatology team. The service specification also sets out that specialised paediatric rheumatology teams will provide transitional care to facilitate transfer and ongoing care in adult rheumatology. Transitional care planning will involve paediatric rheumatology teams, adult rheumatology teams and local hospitals under a shared care arrangement. Specialised paediatric rheumatology services are expected to be commissioned in line with this service specification.
In the NHS Long Term Plan, NHS England committed to delivering a service model for people aged between zero and 25 years old to improve young people’s experience and health outcomes. To aid implementation of this model, the Children and Young People’s Transformation Programme collaborated with key partners to develop national guidance on how the National Health Service can better support young people transfer into adolescent and adult services. The guidance is due to be published shortly and will be hosted on the NHS England website.
The policy aligns with existing National Institute for Health and Care Excellence (NICE) guidelines and outlines the principles and steps of a service model for people aged between zero and 25 years old, along with best practice examples from across the country.
NICE’s published guidance on the transition from children’s to adult services for young people includes recommendations on transition planning, support before and after transfer and the development of transition infrastructure. This guidance is available at the following link:
The Department has not yet considered the recommendations of the report published by the National Confidential Enquiry into Patient Outcome and Death on 13 February 2025, Joint Care? A review of the quality of care provided to children and young adults with juvenile idiopathic arthritis.
NHS England Specialised Commissioning has a Clinical Reference Group for specialised paediatric rheumatology, which has produced a service specification for these services. This service specification names juvenile idiopathic arthritis as one of the conditions that should be managed by a specialist paediatric rheumatology team. The service specification also sets out that specialised paediatric rheumatology teams will provide transitional care to facilitate transfer and ongoing care in adult rheumatology. Transitional care planning will involve paediatric rheumatology teams, adult rheumatology teams and local hospitals under a shared care arrangement. Specialised paediatric rheumatology services are expected to be commissioned in line with this service specification.
In the NHS Long Term Plan, NHS England committed to delivering a service model for people aged between zero and 25 years old to improve young people’s experience and health outcomes. To aid implementation of this model, the Children and Young People’s Transformation Programme collaborated with key partners to develop national guidance on how the National Health Service can better support young people transfer into adolescent and adult services. The guidance is due to be published shortly and will be hosted on the NHS England website.
The policy aligns with existing National Institute for Health and Care Excellence (NICE) guidelines and outlines the principles and steps of a service model for people aged between zero and 25 years old, along with best practice examples from across the country.
NICE’s published guidance on the transition from children’s to adult services for young people includes recommendations on transition planning, support before and after transfer and the development of transition infrastructure. This guidance is available at the following link:
The Department is committed to improving outcomes and patient experience for children, teenagers, and young adults with cancer, from birth to 24 years of age. That is why we have relaunched the Children and Young People Cancer Taskforce, which will identify tangible ways to drive improvements for cancer patients across this age range. The taskforce’s membership, which is currently being finalised, will reflect the diversity of needs across these patient groups.
We recognise that cancer in teenagers and young people is different to cancer in adults and children, and so age-appropriate care is necessary, particularly regarding treatment, diagnosis, and wider support, as per the NHS England service specifications. Department officials are working with chairs of the taskforce to develop the Terms of Reference ahead of the first meeting, currently planned for March. The taskforce will consider the most appropriate dissemination routes or publication channels for taskforce materials in due course.
The Department is committed to improving outcomes and patient experience for children, teenagers, and young adults with cancer, from birth to 24 years of age. That is why we have relaunched the Children and Young People Cancer Taskforce, which will identify tangible ways to drive improvements for cancer patients across this age range. The taskforce’s membership, which is currently being finalised, will reflect the diversity of needs across these patient groups.
We recognise that cancer in teenagers and young people is different to cancer in adults and children, and so age-appropriate care is necessary, particularly regarding treatment, diagnosis, and wider support, as per the NHS England service specifications. Department officials are working with chairs of the taskforce to develop the Terms of Reference ahead of the first meeting, currently planned for March. The taskforce will consider the most appropriate dissemination routes or publication channels for taskforce materials in due course.
The Department is committed to improving outcomes and patient experience for children, teenagers, and young adults with cancer, from birth to 24 years of age. That is why we have relaunched the Children and Young People Cancer Taskforce, which will identify tangible ways to drive improvements for cancer patients across this age range. The taskforce’s membership, which is currently being finalised, will reflect the diversity of needs across these patient groups.
We recognise that cancer in teenagers and young people is different to cancer in adults and children, and so age-appropriate care is necessary, particularly regarding treatment, diagnosis, and wider support, as per the NHS England service specifications. Department officials are working with chairs of the taskforce to develop the Terms of Reference ahead of the first meeting, currently planned for March. The taskforce will consider the most appropriate dissemination routes or publication channels for taskforce materials in due course.
There are nine specialist mesh centres across England, ensuring that women in every region with complications of mesh inserted for urinary incontinence and vaginal prolapse gets the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need, including pain management and psychological support.
According to information held by NHS England, since going live in July 2021, there have been 281 surgical mesh removal operations at the University College London Hospital. Monthly data is not available due to very low patient numbers per month.
There are nine specialist mesh centres across England, ensuring that women in every region with complications of mesh inserted for urinary incontinence and vaginal prolapse get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need, including pain management and psychological support. NHS England publishes data on referral to treatment waiting times. This is available at the following link:
https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/
The Department does not hold information on the average waiting times specifically for mesh centres. Tackling waiting lists is a key part of our Health Mission and we are taking steps to return to the 18-week standard. The Elective Reform Plan sets out how the National Health Service will reform elective care services and meet the 18-week referral to treatment standard by March 2029.
The Department does not hold information on how much each mesh centre received in specialised commissioning funding and on the number of removals that have taken place each month since the service began.
There are nine specialist mesh centres across England, ensuring that women in every region with complications of mesh inserted for urinary incontinence and vaginal prolapse get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need, including pain management and psychological support.
The National Disease Registration Service within NHS England, as the national cancer registry, collects diagnosis and treatment data on cancer patients in England.
Using the data behind the Accredited Official Statistics on Cancer Registrations combined with Cancer Waiting Times data, there were 15,739 patients alive with metastatic breast cancer on 1 January 2023, which is the most recent estimation point available.
This estimate includes patients diagnosed with metastatic, or stage four, breast cancer, as well as breast cancer patients who were diagnosed at stages one, two, or three and who have had a referral for metastatic treatment or palliative care.
The Department continues to advise patients to follow National Health Service guidance on reducing the risk of skin cancer. This advice is available publicly on the National Health Service website, at the following link:
https://www.nhs.uk/conditions/melanoma-skin-cancer/
The Department is not taking any additional steps, currently or within the last three years, to specifically fund skin cancer awareness campaigns.
NHS England run Help Us Help You campaigns to increase knowledge of cancer symptoms and address the barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. The campaigns focus on a range of symptoms as well as encouraging body awareness to help people spot symptoms across a wide range of cancers at an earlier point.
We have committed to develop a 10-year plan to deliver a National Health Service fit for the future. The engagement process has been launched, and as we work to develop and finalise the plan, I would encourage those concerned about excessive exposure to ultraviolet radiation to engage with that process so we can identify what the potential solutions are. Further information is available at the following link:
The Department continues to advise patients to follow National Health Service guidance on sun protection. This advice is available publicly on the NHS.UK website, which is available at the following link:
https://www.nhs.uk/live-well/seasonal-health/sunscreen-and-sun-safety/
It includes guidance on the extra care that should be taken for babies and children.
Research is crucial in tackling cancer, which is why the Department invests over £1.5 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £133 million in 2023/24. Cancer is a major area of NIHR spend, reflecting its high priority. The NIHR has commissioned three current studies relevant to this issue, specifically:
The NIHR's Biomedical Research Centres (BRCs) are networks of experts that work collaboratively between the National Health Service and internationally renowned universities. They facilitate early-stage experimental medicine research and support the translation of scientific discoveries. The BRCs are currently supporting a further two relevant studies:
The NIHR continues to encourage and welcome funding applications for research into any aspect of human health, including cancer. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
The National Disease Registration Service (NDRS) in NHS England, as the national cancer registry, collects diagnosis and treatment data on cancer patients in England. The NDRS does not hold data on the number of people who developed secondary breast cancer after completing the 10-year recommended hormone therapy. Further information on the NDRS is available at the following link:
No recent estimate has been made. Data is only available up to 2020 from the National Disease Registration Service. The data for the year 2020 highlights that 24.4% of bowel cancer patients were diagnosed through emergency presentation.
It is a priority for the Government to support the National Health Service to diagnose cancer, including bowel cancer, as early and as quickly as possible, and to treat it faster, to improve outcomes. The Department is committing to this by improving waiting times for cancer diagnosis and treatment, starting by delivering an extra 40,000 operations, scans, and appointments each week, to support faster diagnosis and access to treatment.
The NHS Bowel Cancer Screening programme currently invites people aged 56 to 74 years old for screening every two years. However, this age cohort is increasing to those aged 50 to 74 years old by 2025, which may reduce the number of late diagnoses.
Furthermore, NHS England runs Help Us Help You campaigns to increase knowledge of cancer symptom and address barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. This campaign urged people to take up the offer of bowel screening when invited.
The Department accepted the Independent Medicines and Medical Devices Safety Review’s recommendation to undertake a selective retrospective audit of a defined cohort of women who have undergone mesh procedures. NHS Digital, now NHS England, has audited all pelvic floor surgeries completed between 2006 and 2011 to generate a historical baseline of outcomes by procedure type, and to support further research and analysis. This audit was conducted using initial procedures, and re-operations and follow up procedures recorded within Hospital Episode Statistics data.
The results are currently undergoing peer review and will be published by NHS England at the earliest opportunity. NHS England expects to be able to notify users of a date for the publication via their publications calendar. Subject to peer review, the publication is expected to include information around data quality.
The Department accepted the Independent Medicines and Medical Devices Safety Review’s recommendation to undertake a selective retrospective audit of a defined cohort of women who have undergone mesh procedures. NHS Digital, now NHS England, has audited all pelvic floor surgeries completed between 2006 and 2011 to generate a historical baseline of outcomes by procedure type, and to support further research and analysis. This audit was conducted using initial procedures, and re-operations and follow up procedures recorded within Hospital Episode Statistics data. The results are currently undergoing peer review and will be published by NHS England at the earliest opportunity.